{"id":654,"date":"2024-03-08T15:40:47","date_gmt":"2024-03-08T14:40:47","guid":{"rendered":"https:\/\/www.novacos-law.com\/en\/?p=654"},"modified":"2024-03-08T15:46:04","modified_gmt":"2024-03-08T14:46:04","slug":"27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs","status":"publish","type":"post","link":"https:\/\/www.novacos-law.com\/en\/2024\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\/","title":{"rendered":"27. Marburger Gespr\u00e4che zum Pharmarecht (March 14 and 15, 2024, Marburg) &#8211; Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs"},"content":{"rendered":"<p>Our partner Maria Heil and senior associate Dr. Julia Eickbusch will speak on the topic of &#8220;Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs&#8221; at the 27th Marburg Talks on Pharmaceutical Law on March 15, 2024. ESG issues will play a major role for the healthcare industry in the future as part of the EU&#8217;s Green Deal. The legal requirements for this are currently being created or tightened by the European legislator. The presentation will provide an overview of the (new) requirements.<\/p>\n<p>Further information can be found <a href=\"https:\/\/www.uni-marburg.de\/de\/fb01\/forschung\/forschungszentrum-und-projekte\/forschungsstellen\/pharmarecht\/veranstaltungen-weiterbildungen\/marburger-gespraeche-zum-pharmarecht\/die-27-marburger-gespraeche-zum-pharmarecht\">here.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Our partner Maria Heil and senior associate Dr. Julia Eickbusch will speak on the topic of &#8220;Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs&#8221; at the 27th Marburg Talks on Pharmaceutical Law on March 15, 2024. ESG issues will play a major role for the healthcare industry in [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[6],"tags":[],"class_list":["post-654","post","type-post","status-publish","format-standard","hentry","category-events"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/posts\/654","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/comments?post=654"}],"version-history":[{"count":0,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/posts\/654\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/media?parent=654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/categories?post=654"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/tags?post=654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}